S100A7A Human

S100 Calcium Binding Protein A7A Human Recombinant
Cat. No.
BT404
Source
Escherichia Coli.
Synonyms
NICE-2, NICE2, Protein S100-A7A, S100A15, S100A7f, S100A7L1, S100 calcium-binding protein A15, S100 calcium-binding protein A7A, S100 calcium-binding protein A7-like 1, S100A7A.
Appearance
Purity
Greater than 90% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The S100A7A Human Recombinant is manufactured with N-terminal fusion of 9 amino acids His Tag. The S100A7A His -Tagged Fusion Protein is a 12.3kDa protein containing 109 amino acid residues and 9 additional amino acid residues - His Tag (underlined).

Product Specs

Introduction
S100A7A plays a role in epidermal differentiation and inflammation, making it relevant to the development of psoriasis and other conditions.
Description
Recombinant Human S100A7A is produced with an N-terminal 9-amino acid His Tag fusion. This His-Tagged S100A7A Fusion Protein has a molecular weight of 12.3kDa, comprising 109 amino acid residues of the protein and an additional 9-amino acid His Tag (underlined).
Formulation
The protein is filtered and lyophilized from a solution of 20mM Tris buffer and 50mM NaCl at pH 7.5, with a concentration of 0.5mg/ml.
Solubility
To prepare a working solution, add pyrogen-free water to the lyophilized pellet to achieve a concentration of 0.5mg/ml. Allow the pellet to dissolve completely. Note: This product is not sterile. Filter through a sterile filter before use in cell culture.
Stability
Store lyophilized Recombinant Human S100A7A at -20°C. After reconstitution, aliquot the product to avoid repeated freeze-thaw cycles. Reconstituted S100A7A remains stable at 4°C for a limited period, showing no changes for up to two weeks.
Purity
Purity is determined to be greater than 90% by SDS-PAGE analysis.
Synonyms
NICE-2, NICE2, Protein S100-A7A, S100A15, S100A7f, S100A7L1, S100 calcium-binding protein A15, S100 calcium-binding protein A7A, S100 calcium-binding protein A7-like 1, S100A7A.
Source
Escherichia Coli.
Amino Acid Sequence
MMKHHHHHHASNT­QAERSIIG MIDMFHKYTG RDGKIEKPSL LTMMKENFPN FLSACDKKGI HYLATVFEKK DKNEDKKIDF SEFLSLLGDI AADYHKQSHG AAPCSGGSQ.

Product Science Overview

Introduction

S100 Calcium Binding Protein A7A, also known as S100A7A or koebnerisin, is a member of the S100 family of proteins. These proteins are characterized by their ability to bind calcium ions, which is crucial for their role in various cellular processes. S100A7A is encoded by the S100A7A gene, which is located on chromosome 1q21.3 in humans .

Function and Expression

S100A7A is involved in several fundamental cellular and extracellular processes, including cell proliferation, differentiation, migration, and antimicrobial defense. It is predominantly expressed in the skin, particularly in the epidermal basal and differentiated keratinocytes, melanocytes, and Langerhans cells. Additionally, it is found in the inner and external root sheath of the pilosebaceous unit and the basal layer of the sebaceous gland .

In the dermis, S100A7A is produced by dendritic cells, smooth muscle cells, endothelial cells, and fibroblasts, playing a role in tissue regeneration. It is also expressed in the breast, where it is found in alveolar and small duct luminal cells, epithelial-derived myoepithelial cells, and surrounding blood vessels .

Role in Disease

S100A7A has been implicated in various diseases, particularly those involving inflammation and cancer. It was first identified as being upregulated in psoriatic skin, suggesting its involvement in the lesional phenotype of psoriasis. The protein is also overexpressed in other inflammatory skin diseases, such as eczema .

In the context of cancer, S100A7A is overexpressed in estrogen receptor/progesterone receptor (ER/PR) negative breast tumors, indicating a potential role in tumor progression. The secreted form of S100A7A acts as a chemoattractant, enhancing inflammation and potentially driving carcinogenesis .

Antimicrobial Properties

S100A7A functions as an antimicrobial peptide (AMP), reducing the survival of bacteria such as Escherichia coli. It is strongly regulated by bacterial components, including those from Pseudomonas aeruginosa and Staphylococcus aureus. This suggests that S100A7A plays a significant role in the antimicrobial defense of the skin and the digestive tract of breast-feeding newborns .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.